{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T12:35:34Z","timestamp":1790858134883,"version":"4.1.0"},"reference-count":99,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Human Immunology"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.humimm.2026.111747","type":"journal-article","created":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T22:19:23Z","timestamp":1778192363000},"page":"111747","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["From discovery to precision tolerance: Re-imagining patient-matched regulatory T cells in shaping of a roadmap for personalized immune re-balancing"],"prefix":"10.1016","volume":"87","author":[{"given":"Saleem","family":"Ahmad","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad Nauman","family":"Aftab","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad Shahbaz","family":"Aslam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.humimm.2026.111747_b0005","unstructured":"Nobel Prize, \u201cNobel Prize in Physiology or Medicine 2025,\u201d NobelPrize.org. Accessed: Oct. 07, 2025. [Online]. Available: Press release. NobelPrize.org. Nobel Prize Outreach 2026. Fri. 16 Jan 2026. <https:\/\/www.nobelprize.org\/prizes\/medicine\/2025\/press-release\/>."},{"issue":"5","key":"10.1016\/j.humimm.2026.111747_b0010","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1016\/j.cell.2008.05.009","article-title":"Regulatory T Cells and Immune Tolerance","volume":"133","author":"Sakaguchi","year":"2008","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.humimm.2026.111747_b0015","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1038\/83713","article-title":"The immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) is caused by mutations of FOXP3","volume":"27","author":"Bennett","year":"2001","journal-title":"Nat. Genet."},{"issue":"5609","key":"10.1016\/j.humimm.2026.111747_b0020","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1126\/science.1079490","article-title":"Control of regulatory T cell development by the transcription factor Foxp3","volume":"299","author":"Hori","year":"2003","journal-title":"Science"},{"key":"10.1016\/j.humimm.2026.111747_b0025","doi-asserted-by":"crossref","unstructured":"S. Sakaguchi, N. Sakaguchi, M. Asano, M. Itoh, and M. Toda, \u201cImmunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases,\u201d J. Immunol. Baltim. Md 1950, vol. 155, no. 3, pp. 1151\u20131164, Aug. 1995.","DOI":"10.4049\/jimmunol.155.3.1151"},{"issue":"2","key":"10.1016\/j.humimm.2026.111747_b0030","doi-asserted-by":"crossref","first-page":"e38","DOI":"10.1371\/journal.pbio.0050038","article-title":"Epigenetic Control of the foxp3 Locus in Regulatory T Cells","volume":"5","author":"Floess","year":"2007","journal-title":"PLoS Biol."},{"key":"10.1016\/j.humimm.2026.111747_b0035","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.609891","article-title":"Targeted De-Methylation of the FOXP3-TSDR is Sufficient to Induce Physiological FOXP3 Expression but not a Functional Treg Phenotype","volume":"11","author":"Kressler","year":"2021","journal-title":"Front. Immunol."},{"issue":"2","key":"10.1016\/j.humimm.2026.111747_b0040","doi-asserted-by":"crossref","first-page":"287","DOI":"10.3390\/biomedicines10020287","article-title":"CAR-T Regulatory (CAR-Treg) Cells: Engineering and applications","volume":"10","author":"Arjomandnejad","year":"2022","journal-title":"Biomedicines"},{"issue":"6","key":"10.1016\/j.humimm.2026.111747_b0045","doi-asserted-by":"crossref","first-page":"2159","DOI":"10.1007\/s10753-024-02031-4","article-title":"Targeted Demethylation of FOXP3-TSDR Enhances the Suppressive Capacity of STAT6-deficient Inducible T Regulatory Cells","volume":"47","author":"Arroyo-Olarte","year":"2024","journal-title":"Inflammation"},{"issue":"5","key":"10.1016\/j.humimm.2026.111747_b0050","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/j.immuni.2020.10.010","article-title":"The Transcription factor Foxp3 Shapes Regulatory T Cell Identity by Tuning the activity of trans-Acting Intermediaries","volume":"53","author":"van der Veeken","year":"2020","journal-title":"Immunity"},{"issue":"1","key":"10.1016\/j.humimm.2026.111747_b0055","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1111\/nyas.13011","article-title":"From IPEX syndrome to FOXP3 mutation: a lesson on immune dysregulation","volume":"1417","author":"Bacchetta","year":"2018","journal-title":"Ann. N. Y. Acad. Sci."},{"issue":"4","key":"10.1016\/j.humimm.2026.111747_b0060","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1038\/ni904","article-title":"Foxp3 programs the development and function of CD4+CD25+ regulatory T cells","volume":"4","author":"Fontenot","year":"2003","journal-title":"Nat. Immunol."},{"issue":"4","key":"10.1016\/j.humimm.2026.111747_b0065","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1002\/eji.200838904","article-title":"Loss of FOXP3 expression in natural human CD4+CD25+ regulatory T cells upon repetitive in vitro stimulation","volume":"39","author":"Hoffmann","year":"2009","journal-title":"Eur. J. Immunol."},{"issue":"5","key":"10.1016\/j.humimm.2026.111747_b0070","doi-asserted-by":"crossref","first-page":"461","DOI":"10.3390\/biomedicines9050461","article-title":"Ectopic FOXP3 Expression in Combination with TGF-\u03b21 and IL-2 Stimulation Generates Limited Suppressive Function in Human Primary Activated Thymocytes Ex Vivo","volume":"9","author":"Gallego-Valle","year":"2021","journal-title":"Biomedicines"},{"issue":"4","key":"10.1016\/j.humimm.2026.111747_b0075","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/j.immuni.2011.02.017","article-title":"Structure of a Domain-Swapped FOXP3 Dimer on DNA and its Function in Regulatory T Cells","volume":"34","author":"Bandukwala","year":"2011","journal-title":"Immunity"},{"issue":"1","key":"10.1016\/j.humimm.2026.111747_b0080","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1093\/cei\/uxad048","article-title":"Development and function of FOXP3+ regulators of immune responses","volume":"213","author":"Golzari-Sorkheh","year":"2023","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.humimm.2026.111747_b0085","article-title":"Targeted De-Methylation of the FOXP3-TSDR is Sufficient to Induce Physiological FOXP3 Expression but not a Functional Treg Phenotype","volume":"11","author":"Kressler","year":"2020","journal-title":"Front. Immunol."},{"issue":"6","key":"10.1016\/j.humimm.2026.111747_b0090","doi-asserted-by":"crossref","first-page":"1654","DOI":"10.1002\/eji.200838105","article-title":"DNA methylation controls Foxp3 gene expression","volume":"38","author":"Polansky","year":"2008","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.humimm.2026.111747_b0095","doi-asserted-by":"crossref","DOI":"10.1016\/j.cellimm.2021.104471","article-title":"CRISPR\/Cas9-mediated demethylation of FOXP3-TSDR toward Treg-characteristic programming of Jurkat T cells","volume":"371","author":"Wilk","year":"2022","journal-title":"Cell. Immunol."},{"key":"10.1016\/j.humimm.2026.111747_b0100","doi-asserted-by":"crossref","unstructured":"C. Gootjes, J. J. Zwaginga, B. O. Roep, and T. Nikolic, \u201cDefining Human Regulatory T Cells beyond FOXP3: The Need to Combine Phenotype with Function,\u201d Cells, vol. 13, no. 11, May 2024, doi: 10.3390\/cells13110941.","DOI":"10.3390\/cells13110941"},{"issue":"11","key":"10.1016\/j.humimm.2026.111747_b0105","doi-asserted-by":"crossref","first-page":"2059","DOI":"10.1038\/s41590-025-02295-4","article-title":"Temporal and context-dependent requirements for the transcription factor Foxp3 expression in regulatory T cells","volume":"26","author":"Hu","year":"2025","journal-title":"Nat. Immunol."},{"issue":"8","key":"10.1016\/j.humimm.2026.111747_b0110","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2023.113018","article-title":"Mutations from patients with IPEX ported to mice reveal different patterns of FoxP3 and Treg dysfunction","volume":"42","author":"Leon","year":"2023","journal-title":"Cell Rep."},{"key":"10.1016\/j.humimm.2026.111747_b0115","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2019.00881","article-title":"Scurfy mice develop Features of Connective Tissue Disease Overlap Syndrome and mixed Connective Tissue Disease in the Absence of Regulatory T Cells","volume":"10","author":"Yilmaz","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.humimm.2026.111747_b0120","doi-asserted-by":"crossref","unstructured":"K. B\u00f6r\u00f6cz, D. Szinger, D. Simon, T. Berki, and P. N\u00e9meth, \u201cRegulators and Conductors of Immunity: Natural Immune System in Health and Autoimmunity,\u201d Int. J. Mol. Sci., vol. 26, no. 11, Jun. 2025, doi: 10.3390\/ijms26115413.","DOI":"10.3390\/ijms26115413"},{"key":"10.1016\/j.humimm.2026.111747_b0125","doi-asserted-by":"crossref","unstructured":"H. Chang, Y. Wang, L. Gao, and S. J. Zheng, \u201cBeyond Conventional Transcriptional Regulation Function: FOXP3 as an Integrative Hub for Chromatin Interactions and Protein Complexes in Immune Regulation,\u201d Biology, vol. 15, no. 3, Jan. 2026, doi: 10.3390\/biology15030254.","DOI":"10.3390\/biology15030254"},{"issue":"5","key":"10.1016\/j.humimm.2026.111747_b0130","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1038\/s41422-024-00941-4","article-title":"T follicular regulatory cells keep B cell-directed autoreactivity in check","volume":"34","author":"Ribeiro","year":"2024","journal-title":"Cell Res."},{"key":"10.1016\/j.humimm.2026.111747_b0135","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2025.1686687","article-title":"Follicular helper T cells (Tfh): heterogeneity in spatial distribution and phenotypic characteristics","volume":"16","author":"Shen","year":"2025","journal-title":"Front. Immunol."},{"key":"10.1016\/j.humimm.2026.111747_b0140","doi-asserted-by":"crossref","unstructured":"L. Graca, J. Jacobsen, and S. Kumar, \u201cThe expanding family of T follicular regulatory cells,\u201d Sci. Immunol., vol. 8, no. 82, p. eadg7526, Apr. 2023, doi: 10.1126\/sciimmunol.adg7526.","DOI":"10.1126\/sciimmunol.adg7526"},{"issue":"1","key":"10.1016\/j.humimm.2026.111747_b0145","doi-asserted-by":"crossref","first-page":"e8","DOI":"10.4110\/in.2024.24.e8","article-title":"Cytokines in Follicular Helper T Cell Biology in Physiologic and Pathologic Conditions","volume":"24","author":"Choi","year":"2024","journal-title":"Immune Netw."},{"key":"10.1016\/j.humimm.2026.111747_b0150","doi-asserted-by":"crossref","first-page":"4706","DOI":"10.1038\/s41467-019-12464-3","article-title":"Single-cell transcriptomics of human T cells reveals tissue and activation signatures in health and disease","volume":"10","author":"Szabo","year":"2019","journal-title":"Nat. Commun."},{"issue":"2","key":"10.1016\/j.humimm.2026.111747_b0155","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1038\/nri2916","article-title":"Phenotypic and functional specialization of FOXP3+ regulatory T cells","volume":"11","author":"Campbell","year":"2011","journal-title":"Nat. Rev. Immunol."},{"issue":"2","key":"10.1016\/j.humimm.2026.111747_b0160","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/j.immuni.2019.01.001","article-title":"Single-Cell Transcriptomics of Regulatory T Cells reveals Trajectories of Tissue Adaptation","volume":"50","author":"Miragaia","year":"2019","journal-title":"Immunity"},{"issue":"6","key":"10.1016\/j.humimm.2026.111747_b0165","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1016\/j.cell.2013.10.054","article-title":"A special Population of Regulatory T Cells Potentiates Muscle Repair","volume":"155","author":"Burzyn","year":"2013","journal-title":"Cell"},{"issue":"5","key":"10.1016\/j.humimm.2026.111747_b0170","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1016\/j.immuni.2016.10.021","article-title":"Transcriptional Landscape of Human Tissue Lymphocytes Unveils Uniqueness of Tumor-Infiltrating T Regulatory Cells","volume":"45","author":"De Simone","year":"2016","journal-title":"Immunity"},{"issue":"5","key":"10.1016\/j.humimm.2026.111747_b0175","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1016\/j.immuni.2016.10.032","article-title":"Regulatory T Cells exhibit Distinct Features in Human Breast Cancer","volume":"45","author":"Plitas","year":"2016","journal-title":"Immunity"},{"issue":"1","key":"10.1016\/j.humimm.2026.111747_b0180","doi-asserted-by":"crossref","first-page":"2710","DOI":"10.1038\/s41467-021-22975-7","article-title":"Conserved human effector Treg cell transcriptomic and epigenetic signature in arthritic joint inflammation","volume":"12","author":"Mijnheer","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.humimm.2026.111747_b0185","doi-asserted-by":"crossref","unstructured":"G. Plitas and A. Y. Rudensky, \u201cRegulatory T Cells in Cancer,\u201d Annu. Rev. Cancer Biol., vol. 4, no. Volume 4, 2020, pp. 459\u2013477, Mar. 2020, doi: 10.1146\/annurev-cancerbio-030419-033428.","DOI":"10.1146\/annurev-cancerbio-030419-033428"},{"key":"10.1016\/j.humimm.2026.111747_b0190","doi-asserted-by":"crossref","first-page":"14030","DOI":"10.1038\/mtm.2014.30","article-title":"Ex vivo expanded autologous polyclonal regulatory T cells suppress inhibitor formation in hemophilia","volume":"1","author":"Sarkar","year":"2014","journal-title":"Mol. Ther. Methods Clin. Dev."},{"issue":"4","key":"10.1016\/j.humimm.2026.111747_b0195","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.jaut.2007.12.012","article-title":"Combination of Rapamycin and IL-2 increases De Novo Induction of Human CD4+CD25+FOXP3+ T Cells","volume":"30","author":"Long","year":"2008","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.humimm.2026.111747_b0200","doi-asserted-by":"crossref","unstructured":"K. L. Hippen et al., \u201cMassive ex vivo expansion of human natural regulatory T cells (Tregs) with minimal loss of in vivo functional activity,\u201d Sci. Transl. Med., vol. 3, no. 83, p. 83ra41, May 2011, doi: 10.1126\/scitranslmed.3001809.","DOI":"10.1126\/scitranslmed.3001809"},{"issue":"1","key":"10.1016\/j.humimm.2026.111747_b0205","doi-asserted-by":"crossref","first-page":"7428","DOI":"10.1038\/s41598-018-25574-7","article-title":"A phase I Clinical Trial with Ex Vivo Expanded Recipient Regulatory T cells in living Donor Kidney Transplants","volume":"8","author":"Mathew","year":"2018","journal-title":"Sci. Rep."},{"issue":"22","key":"10.1016\/j.humimm.2026.111747_b0210","doi-asserted-by":"crossref","first-page":"2067","DOI":"10.1056\/NEJMoa1105143","article-title":"Regulatory T-Cell responses to Low-Dose Interleukin-2 in HCV-Induced Vasculitis","volume":"365","author":"Saadoun","year":"2011","journal-title":"N. Engl. J. Med."},{"issue":"1","key":"10.1016\/j.humimm.2026.111747_b0215","doi-asserted-by":"crossref","first-page":"7324","DOI":"10.1038\/s41467-022-34162-3","article-title":"Low-dose IL-2 reduces IL-21+ T cell frequency and induces anti-inflammatory gene expression in type 1 diabetes","volume":"13","author":"Zhang","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.humimm.2026.111747_b0220","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2022.1081644","article-title":"Clinical adoptive regulatory T Cell therapy: State of the art, challenges, and prospective","volume":"10","author":"Amini","year":"2023","journal-title":"Front. Cell Dev. Biol."},{"issue":"9","key":"10.1016\/j.humimm.2026.111747_b0225","doi-asserted-by":"crossref","first-page":"2237","DOI":"10.1111\/ajt.17063","article-title":"Anti-HLA-A2-CAR Tregs prolong vascularized mouse heterotopic heart allograft survival","volume":"22","author":"Wagner","year":"2022","journal-title":"Am. J. Transplant. off. J. Am. Soc. Transplant. Am. Soc. Transpl. Surg."},{"issue":"4","key":"10.1016\/j.humimm.2026.111747_b0230","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1172\/JCI82771","article-title":"Alloantigen-specific regulatory T cells generated with a chimeric antigen receptor","volume":"126","author":"MacDonald","year":"2016","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.humimm.2026.111747_b0235","doi-asserted-by":"crossref","unstructured":"Y. Cui et al., \u201cIL23R-Specific CAR Tregs for the Treatment of Crohn\u2019s Disease,\u201d J. Crohns Colitis, vol. 19, no. 3, p. jjae135, Mar. 2025, doi: 10.1093\/ecco-jcc\/jjae135.","DOI":"10.1093\/ecco-jcc\/jjae135"},{"key":"10.1016\/j.humimm.2026.111747_b0240","unstructured":"City of Hope Medical Center Trial, \u201cAllogeneic CD6 Chimeric Antigen Receptor T Regulatory Cells (CD6-CAR Tregs) for the Treatment of Patients With Chronic Graft Versus Host Disease After Allogeneic Hematopoietic Cell Transplantation | Clinical Research Trial Listing (Hematologic and Lymphocytic Disorder | Steroid Refractory Graft Versus Host Disease | Chronic Graft Versus Host Disease) (NCT05993611).\u201d."},{"issue":"8","key":"10.1016\/j.humimm.2026.111747_b0245","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1093\/intimm\/dxx049","article-title":"Improvement of Foxp3 stability through CNS2 demethylation by TET enzyme induction and activation","volume":"29","author":"Someya","year":"2017","journal-title":"Int. Immunol."},{"key":"10.1016\/j.humimm.2026.111747_b0250","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.609891","article-title":"Targeted De-Methylation of the FOXP3-TSDR is Sufficient to Induce Physiological FOXP3 Expression but not a Functional Treg Phenotype","volume":"11","author":"Kressler","year":"2021","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.humimm.2026.111747_b0255","doi-asserted-by":"crossref","DOI":"10.1080\/15476278.2022.2164159","article-title":"Clinical Manufacturing of Regulatory T Cell Products for Adoptive Cell Therapy and strategies to Improve Therapeutic Efficacy","volume":"19","author":"Baron","year":"2023","journal-title":"Organogenesis"},{"issue":"13","key":"10.1016\/j.humimm.2026.111747_b0260","doi-asserted-by":"crossref","first-page":"6371","DOI":"10.3390\/ijms26136371","article-title":"Epigenome Engineering using dCas Systems for Biomedical Applications and Biotechnology: Current Achievements, Opportunities and challenges","volume":"26","author":"Kovalev","year":"2025","journal-title":"Int. J. Mol. Sci."},{"issue":"6","key":"10.1016\/j.humimm.2026.111747_b0265","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2022.111606","article-title":"Single-cell transcriptome profiling and chromatin accessibility reveal an exhausted regulatory CD4+ T cell subset in systemic lupus erythematosus","volume":"41","author":"Guo","year":"2022","journal-title":"Cell Rep."},{"key":"10.1016\/j.humimm.2026.111747_b0270","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.619932","article-title":"Single-Cell Sequencing reveals the Transcriptome and TCR Characteristics of pTregs and in vitro Expanded iTregs","volume":"12","author":"Hui","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.humimm.2026.111747_b0275","doi-asserted-by":"crossref","unstructured":"T. Sj\u00f8gren et al., \u201cSingle cell characterization of blood and expanded regulatory T cells in autoimmune polyendocrine syndrome type 1,\u201d iScience, vol. 27, no. 4, Apr. 2024, doi: 10.1016\/j.isci.2024.109610.","DOI":"10.1016\/j.isci.2024.109610"},{"key":"10.1016\/j.humimm.2026.111747_b0280","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.jaut.2017.07.009","article-title":"Cells with Treg-specific FOXP3 demethylation but low CD25 are prevalent in autoimmunity","volume":"84","author":"Ferreira","year":"2017","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.humimm.2026.111747_b0285","article-title":"Transcriptional fingerprinting of regulatory T cells: ensuring quality in cell therapy applications","volume":"16","author":"Cheng","year":"2025","journal-title":"Front. Immunol."},{"issue":"3","key":"10.1016\/j.humimm.2026.111747_b0290","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1038\/s41434-022-00358-x","article-title":"Preclinical assessment of antigen-specific chimeric antigen receptor regulatory T cells for use in solid organ transplantation","volume":"30","author":"Proics","year":"2023","journal-title":"Gene Ther."},{"key":"10.1016\/j.humimm.2026.111747_b0295","doi-asserted-by":"crossref","unstructured":"G. I. Uenishi et al., \u201cGNTI-122: an autologous antigen-specific engineered Treg cell therapy for type 1 diabetes,\u201d JCI Insight, vol. 9, no. 6, Mar. 2024, doi: 10.1172\/jci.insight.171844.","DOI":"10.1172\/jci.insight.171844"},{"issue":"1","key":"10.1016\/j.humimm.2026.111747_b0300","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1186\/s40364-023-00534-0","article-title":"Neoantigen-targeted TCR-engineered T cell immunotherapy: current advances and challenges","volume":"11","author":"Pang","year":"2023","journal-title":"Biomark. Res."},{"issue":"6","key":"10.1016\/j.humimm.2026.111747_b0305","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1016\/j.cmet.2016.12.018","article-title":"Foxp3 reprograms T cell metabolism to function in low glucose high lactate environments","volume":"25","author":"Angelin","year":"2017","journal-title":"Cell Metab."},{"key":"10.1016\/j.humimm.2026.111747_b0310","doi-asserted-by":"crossref","unstructured":"D. Howie et al., \u201cFoxp3 drives oxidative phosphorylation and protection from lipotoxicity,\u201d JCI Insight, vol. 2, no. 3, p. e89160, doi: 10.1172\/jci.insight.89160.","DOI":"10.1172\/jci.insight.89160"},{"key":"10.1016\/j.humimm.2026.111747_b0315","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaut.2023.103057","article-title":"Supraphysiological FOXP3 expression in human CAR-Tregs results in improved stability, efficacy, and safety of CAR-Treg products for clinical application","volume":"138","author":"Henschel","year":"2023","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.humimm.2026.111747_b0320","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.686439","article-title":"Precision Engineering of an Anti-HLA-A2 Chimeric Antigen Receptor in Regulatory T Cells for Transplant Immune Tolerance","volume":"12","author":"Muller","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.humimm.2026.111747_b0325","doi-asserted-by":"crossref","unstructured":"C. M. Wardell et al., \u201cCAR Treg cells mediate linked suppression and infectious tolerance in islet transplantation in mice,\u201d Sci. Transl. Med., vol. 17, no. 812, p. eadp6519, Aug. 2025, doi: 10.1126\/scitranslmed.adp6519.","DOI":"10.1126\/scitranslmed.adp6519"},{"issue":"2","key":"10.1016\/j.humimm.2026.111747_b0330","doi-asserted-by":"crossref","first-page":"E156","DOI":"10.1073\/pnas.1408686111","article-title":"Polymeric synthetic nanoparticles for the induction of antigen-specific immunological tolerance","volume":"112","author":"Maldonado","year":"2015","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"1","key":"10.1016\/j.humimm.2026.111747_b0335","doi-asserted-by":"crossref","first-page":"19120","DOI":"10.1038\/s41598-020-76109-y","article-title":"Butyrate induced Tregs are capable of migration from the GALT to the pancreas to restore immunological tolerance during type-1 diabetes","volume":"10","author":"Jacob","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.humimm.2026.111747_b0340","doi-asserted-by":"crossref","DOI":"10.1099\/jmm.0.002117","article-title":"SCFAs\u2019 pleiotropic role in pathogenesis and salutogenesis: mechanisms in exacerbation and regulation of inflammation and fibrosis from gut to host","author":"Ahmad","year":"2026","journal-title":"J. Med. Microbiol."},{"key":"10.1016\/j.humimm.2026.111747_b0345","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.712870","article-title":"Antigen-specific Treg Therapy in Type 1 Diabetes \u2013 challenges and Opportunities","volume":"12","author":"Serr","year":"2021","journal-title":"Front. Immunol."},{"issue":"10","key":"10.1016\/j.humimm.2026.111747_b0350","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1080\/13543784.2021.1974396","article-title":"Anti-integrin drugs in clinical trials for inflammatory bowel disease (IBD): insights into promising agents","volume":"30","author":"Solitano","year":"2021","journal-title":"Expert Opin. Investig. Drugs"},{"issue":"7","key":"10.1016\/j.humimm.2026.111747_b0355","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1038\/s41590-025-02172-0","article-title":"PD-1 receptor deficiency enhances CD30+ Treg cell function in melanoma","volume":"26","author":"Lim","year":"2025","journal-title":"Nat. Immunol."},{"issue":"20","key":"10.1016\/j.humimm.2026.111747_b0360","doi-asserted-by":"crossref","first-page":"9999","DOI":"10.1073\/pnas.1822001116","article-title":"PD-1+ regulatory T cells amplified by PD-1 blockade promote hyperprogression of cancer","volume":"116","author":"Kamada","year":"2019","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"11","key":"10.1016\/j.humimm.2026.111747_b0365","doi-asserted-by":"crossref","first-page":"4247","DOI":"10.1182\/blood-2004-11-4564","article-title":"An inducible caspase 9 safety switch for T-cell therapy","volume":"105","author":"Straathof","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.humimm.2026.111747_b0370","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2025.1621396","article-title":"Treg cell plasticity as a driver of inflammation in spondyloarthritis and psoriasis","volume":"16","author":"Ortega-Mejia","year":"2025","journal-title":"Front. Immunol."},{"key":"10.1016\/j.humimm.2026.111747_b0375","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1533823","article-title":"Elusive modes of Foxp3 activity in versatile regulatory T cells","volume":"15","author":"He","year":"2025","journal-title":"Front. Immunol."},{"key":"10.1016\/j.humimm.2026.111747_b0380","doi-asserted-by":"crossref","unstructured":"J. M. Umhoefer et al., \u201cCis-Regulatory Element and Transcription Factor Circuitry Required for Cell-Type Specific Expression of FOXP3,\u201d BioRxiv Prepr. Serv. Biol., p. 2024.08.30.610436, Jan. 2025, doi: 10.1101\/2024.08.30.610436.","DOI":"10.1101\/2024.08.30.610436"},{"key":"10.1016\/j.humimm.2026.111747_b0385","doi-asserted-by":"crossref","unstructured":"R. W. Cochrane et al., \u201cHigh affinity chimeric antigen receptor signaling induces an inflammatory program in human regulatory T cells,\u201d bioRxiv, p. 2024.03.31.587467, Apr. 2024, doi: 10.1101\/2024.03.31.587467.","DOI":"10.1101\/2024.03.31.587467"},{"key":"10.1016\/j.humimm.2026.111747_b0390","doi-asserted-by":"crossref","unstructured":"M. Arjomandnejad, A. L. Kopec, and A. M. Keeler, \u201cCAR-T Regulatory (CAR-Treg) Cells: Engineering and Applications,\u201d Biomedicines, vol. 10, no. 2, Jan. 2022, doi: 10.3390\/biomedicines10020287.","DOI":"10.3390\/biomedicines10020287"},{"key":"10.1016\/j.humimm.2026.111747_b0395","doi-asserted-by":"crossref","unstructured":"C. Lamarche et al., \u201cTonic-signaling chimeric antigen receptors drive human regulatory T cell exhaustion,\u201d Proc. Natl. Acad. Sci. U. S. A., vol. 120, no. 14, p. e2219086120, doi: 10.1073\/pnas.2219086120.","DOI":"10.1073\/pnas.2219086120"},{"key":"10.1016\/j.humimm.2026.111747_b0400","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.1005582","article-title":"Membrane-bound IL-2 improves the expansion, survival, and phenotype of CAR Tregs and confers resistance to calcineurin inhibitors","volume":"13","author":"Kremer","year":"2022","journal-title":"Front. Immunol."},{"issue":"8066","key":"10.1016\/j.humimm.2026.111747_b0405","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1038\/s41586-025-08795-5","article-title":"Genome-wide CRISPR screen in human T cells reveals regulators of FOXP3","volume":"642","author":"Chen","year":"2025","journal-title":"Nature"},{"key":"10.1016\/j.humimm.2026.111747_b0410","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.926550","article-title":"Emerging translational strategies and challenges for enhancing regulatory T cell therapy for graft-versus-host disease","volume":"13","author":"Hippen","year":"2022","journal-title":"Front. Immunol."},{"issue":"2","key":"10.1016\/j.humimm.2026.111747_b0415","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1038\/s41590-024-02062-x","article-title":"Differential roles of human CD4+ and CD8+ regulatory T cells in controlling self-reactive immune responses","volume":"26","author":"Chen","year":"2025","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.humimm.2026.111747_b0420","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1463971","article-title":"Regulatory CD4+ T cells redirected against pathogenic CD8+ T cells protect NOD mice from development of autoimmune diabetes","volume":"15","author":"Kakabadse","year":"2024","journal-title":"Front. Immunol."},{"key":"10.1016\/j.humimm.2026.111747_b0425","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2025.1626085","article-title":"Navigating the manufacturing, testing and regulatory complexities of regulatory T cells for adoptive cell therapy","volume":"16","author":"Pikor","year":"2025","journal-title":"Front. Immunol."},{"issue":"8","key":"10.1016\/j.humimm.2026.111747_b0430","doi-asserted-by":"crossref","first-page":"2342","DOI":"10.1182\/blood-2010-10-313684","article-title":"Rapamycin and IL-2 reduce lethal acute graft-versus-host disease associated with increased expansion of donor type CD4+CD25+Foxp3+ regulatory T cells","volume":"118","author":"Shin","year":"2011","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.humimm.2026.111747_b0435","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1186\/s12967-025-06561-9","article-title":"Clinical grade expansion protocol for the manufacture of thymus-derived Treg cells for clinical application","volume":"23","author":"Fanelli","year":"2025","journal-title":"J. Transl. Med."},{"issue":"1","key":"10.1016\/j.humimm.2026.111747_b0440","doi-asserted-by":"crossref","DOI":"10.1016\/j.omtm.2023.101170","article-title":"The comparability tales: a phase-appropriate roadmap for CGT drug product development","volume":"32","author":"Cl\u00e9ment","year":"2023","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.humimm.2026.111747_b0445","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2023.1090721","article-title":"Barriers to Treg therapy in Europe: from production to regulation","volume":"10","author":"Hennessy","year":"2023","journal-title":"Front. Med."},{"key":"10.1016\/j.humimm.2026.111747_b0450","doi-asserted-by":"crossref","DOI":"10.1155\/2018\/3758713","article-title":"Description of CD8+ Regulatory T Lymphocytes and their specific intervention in Graft-versus-Host and Infectious Diseases, Autoimmunity, and Cancer","volume":"2018","author":"Vieyra-Lobato","year":"2018","journal-title":"J. Immunol. Res."},{"issue":"6","key":"10.1016\/j.humimm.2026.111747_b0455","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1615\/CritRevImmunol.2020033260","article-title":"Advances in the Study of CD8+ Regulatory T Cells","volume":"39","author":"Tang","year":"2019","journal-title":"Crit. Rev. Immunol."},{"issue":"4","key":"10.1016\/j.humimm.2026.111747_b0460","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2024.107134","article-title":"Cellular and molecular signaling towards T cell immunological self-tolerance","volume":"300","author":"Carbone","year":"2024","journal-title":"J. Biol. Chem."},{"issue":"4","key":"10.1016\/j.humimm.2026.111747_b0465","doi-asserted-by":"crossref","first-page":"2085","DOI":"10.3390\/ijms27042085","article-title":"Cytokines Associated with Activation of CD4+CD25+Foxp3+ T Regulatory Cells","volume":"27","author":"Al-atiyah","year":"2026","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.humimm.2026.111747_b0470","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejim.2025.106505","article-title":"T follicular helper cells (TFH): from physiological to pathological aging","volume":"141","author":"de Lisio","year":"2025","journal-title":"Eur. J. Intern. Med."},{"key":"10.1016\/j.humimm.2026.111747_b0475","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.679909","article-title":"T Follicular Regulatory Cells: Choreographers of Productive Germinal Center responses","volume":"12","author":"Lu","year":"2021","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.humimm.2026.111747_b0480","doi-asserted-by":"crossref","first-page":"e10","DOI":"10.4110\/in.2026.26.e10","article-title":"Regulatory T Cell Heterogeneity in the Steady State and Tumor","volume":"26","author":"Kim","year":"2026","journal-title":"Immune Netw."},{"issue":"3","key":"10.1016\/j.humimm.2026.111747_b0485","doi-asserted-by":"crossref","DOI":"10.1016\/j.omtm.2025.101561","article-title":"HLA-A2 CAR\/IL-2-CISC engineered Treg display robust in vitro and in vivo antigen-specific regulatory function","volume":"33","author":"Tripathi","year":"2025","journal-title":"Mol. Ther. Methods Clin. Dev."},{"issue":"11","key":"10.1016\/j.humimm.2026.111747_b0490","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1182\/blood.2022018440","article-title":"Prevention of acute GVHD using an orthogonal IL-2\/IL-2R\u03b2 system to selectively expand regulatory Tcells invivo","volume":"141","author":"Ramos","year":"2023","journal-title":"Blood"},{"key":"10.1016\/j.humimm.2026.111747_b0495","doi-asserted-by":"crossref","unstructured":"X. Rui et al., \u201cHuman OX40L\u2013CAR-Tregs target activated antigen-presenting cells and control T cell alloreactivity,\u201d Sci. Transl. Med., vol. 16, no. 769, p. eadj9331, Oct. 2024, doi: 10.1126\/scitranslmed.adj9331.","DOI":"10.1126\/scitranslmed.adj9331"}],"container-title":["Human Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0198885926000935?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0198885926000935?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T16:10:06Z","timestamp":1781280606000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0198885926000935"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":99,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["S0198885926000935"],"URL":"https:\/\/doi.org\/10.1016\/j.humimm.2026.111747","relation":{},"ISSN":["0198-8859"],"issn-type":[{"value":"0198-8859","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"From discovery to precision tolerance: Re-imagining patient-matched regulatory T cells in shaping of a roadmap for personalized immune re-balancing","name":"articletitle","label":"Article Title"},{"value":"Human Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.humimm.2026.111747","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 American Society for Histocompatibility and Immunogenetics. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"111747"}}